Sunburn — The morning read of what s hot in Florida politics — 8 13 21 floridapolitics.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from floridapolitics.com Daily Mail and Mail on Sunday newspapers.
BioNTech, Moderna shore up supplies of key COVID-19 vaccine ingredients
FILE PHOTO: A nurse fills a syringe with a second dose of the Pfizer-BioNTech COVID-19 vaccine, as the coronavirus disease (COVID-19) outbreak continues, at Enfermera Isabel Zendal new pandemic hospital in Madrid, Spain, February 4, 2021. REUTERS/Sergio Perez/File Photo reuters tickers
This content was published on February 12, 2021 - 13:29
February 12, 2021 - 13:29
By Allison Martell, Ludwig Burger and Chad Terhune
(Reuters) - Vaccine makers are shoring up their supply of a critical raw material in messenger RNA vaccines: the lipid molecules that help deliver the genetic RNA material into cells.
Manufacturers are under pressure to increase production of COVID-19 vaccines as infections from the pandemic approach 110 million people.
Vaccine makers are shoring up their supply of a critical raw material in "messenger RNA" vaccines: the lipid molecules that help deliver the genetic RNA material into cells.
12 Min Read
(Reuters) - Newly unsealed court documents and other records show that Merck & Co and U.S. regulators knew about reports of suicidal behavior in men taking the company’s anti-baldness treatment Propecia when they decided not to warn consumers of those potential risks in a 2011 update of the popular drug’s label.
FILE PHOTO: A bottle of Propecia is seen on a pharmacy shelf in New York City, U.S., August 8, 2019. REUTERS/Zachary Goelman
Internal records from Merck were made public in late January, when a federal magistrate in Brooklyn, New York, granted a 2019 Reuters motion to unseal 11 documents filed in years of litigation alleging Propecia caused persistent sexual dysfunction and other harmful side effects.